14-77214730-A-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_020431.4(TMEM63C):c.-14+1222A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.256 in 151,108 control chromosomes in the GnomAD database, including 6,258 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.26 ( 6258 hom., cov: 28)
Consequence
TMEM63C
NM_020431.4 intron
NM_020431.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.874
Publications
2 publications found
Genes affected
TMEM63C (HGNC:23787): (transmembrane protein 63C) Enables calcium activated cation channel activity. Involved in cation transport. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. Biomarker of focal segmental glomerulosclerosis. [provided by Alliance of Genome Resources, Apr 2022]
TMEM63C Gene-Disease associations (from GenCC):
- spastic paraplegia 87, autosomal recessiveInheritance: AR Classification: MODERATE, LIMITED Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.595 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TMEM63C | NM_020431.4 | c.-14+1222A>C | intron_variant | Intron 2 of 23 | ENST00000298351.5 | NP_065164.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.257 AC: 38742AN: 150986Hom.: 6253 Cov.: 28 show subpopulations
GnomAD3 genomes
AF:
AC:
38742
AN:
150986
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.256 AC: 38745AN: 151108Hom.: 6258 Cov.: 28 AF XY: 0.260 AC XY: 19152AN XY: 73750 show subpopulations
GnomAD4 genome
AF:
AC:
38745
AN:
151108
Hom.:
Cov.:
28
AF XY:
AC XY:
19152
AN XY:
73750
show subpopulations
African (AFR)
AF:
AC:
3422
AN:
41120
American (AMR)
AF:
AC:
3459
AN:
15198
Ashkenazi Jewish (ASJ)
AF:
AC:
960
AN:
3466
East Asian (EAS)
AF:
AC:
3121
AN:
5090
South Asian (SAS)
AF:
AC:
2362
AN:
4774
European-Finnish (FIN)
AF:
AC:
2886
AN:
10420
Middle Eastern (MID)
AF:
AC:
90
AN:
290
European-Non Finnish (NFE)
AF:
AC:
21598
AN:
67748
Other (OTH)
AF:
AC:
547
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1299
2599
3898
5198
6497
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
420
840
1260
1680
2100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1742
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.